Daniel SontupeMarket Access
Frank BurrellScientific Storytelling
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Matthew DurhamOmnidynamic Marketing
Stacey GandlerBrand Nourishment
Suma Ramadas, PhDMedical Affairs
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Pat PurcellMeeting Engagement
Median overall survival of 23.7 months following CMB305 monotherapy represents approximately one-year extension of ...
ASTRAZENECA COMPLETES AGREEMENT WITH TILLOTTS PHARMA FOR ENTOCORT AstraZeneca today announced that it has ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email